What is Oramed Pharmaceuticals Inc. (ORMP.TA)?

Oramed Pharmaceuticals Inc. (ORMP.TA) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

Oramed Pharmaceuticals Inc. (ORMP.TA)

Stock analysis · TLV · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.20

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Oramed Pharmaceuticals Inc. (ORMP.TA) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Aug 10, 2026

EPS $8.22 vs est. $1.28

Beat by $6.94

Proprietary Signals

Signal snapshot temporarily unavailable.

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.